Efficacy and safety in patients with psoriasis treated continuously with adalimumab for approximately 3 years

被引:0
|
作者
Gordon, Kenneth [1 ]
Sasso, Eric [2 ]
Gu, Yihua [2 ]
Poulin, Yves [3 ]
机构
[1] NorthShore Univ HealthSystem, Evanston, IL USA
[2] Abbott, Abbott Pk, IL USA
[3] Ctr Dermatol Quebec Metropolitain, Quebec City, PQ, Canada
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:AB140 / AB140
页数:1
相关论文
共 50 条
  • [1] Efficacy and safety of adalimumab in patients with psoriasis treated continuously for over 3 years
    Gordon, K.
    Poulin, Y.
    Gu, Y.
    Sasso, E. H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2010, 24 : 28 - 28
  • [2] Psoriasis patients treated continuously with adalimumab: Efficacy and safety results from months 12 to 18
    Gordon, Kenneth
    Tyring, Stephen
    Go, Yihua
    Okun, Martin
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB129 - AB129
  • [3] Methotrexate-treated psoriasis patients transitioning to adalimumab: Efficacy and safety outcomes
    Mrowietz, Ulrich
    Go, Yihua
    Okun, Martin
    Luger, Thomas
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB120 - AB120
  • [4] Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEAL
    Gordon, Kenneth
    Papp, Kim
    Poulin, Yves
    Gu, Yihua
    Rozzo, Stephen
    Sasso, Eric H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (02) : 241 - 251
  • [5] Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis
    Menter, Alan
    Gordon, Kenneth B.
    Leonardi, Craig L.
    Gu, Yihua
    Goldblum, Orin M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (03) : 448 - 456
  • [6] Efficacy and safety outcomes for psoriasis patients who interrupt, then resume, adalimumab therapy
    Papp, Kim
    Crowley, Jeffrey
    Okun, Martin
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB159 - AB159
  • [7] Safety and efficacy of adalimumab treatment in Japanese patients with psoriasis: Results of SALSA study
    Asahina, Akihiko
    Torii, Hideshi
    Ohtsuki, Mamitaro
    Tokimoto, Toshimitsu
    Hase, Hidenori
    Tsuchiya, Tsuyoshi
    Shinmura, Yasuhiko
    Servin, Ofelia Reyes
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2016, 43 (11): : 1257 - 1266
  • [8] Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
    Li, Changkun
    Sunhe, Yixuan
    Zhou, Hui
    Dong, Weihua
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [9] Efficacy and safety of adalimumab in difficult-to-treat psoriasis
    Lanna, Caterina
    Zangrilli, Arianna
    Bavetta, Mauro
    Campione, Elena
    Bianchi, Luca
    DERMATOLOGIC THERAPY, 2020, 33 (03)
  • [10] Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE
    Ortonne, J. -P.
    Chimenti, S.
    Reich, K.
    Gniadecki, R.
    Sprogel, P.
    Unnebrink, K.
    Kupper, H.
    Goldblum, O.
    Thaci, D.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (09) : 1012 - 1020